Ultragenyx director sells 2,000 shares in market
Ultragenyx Pharmaceutical Inc. director Sanders Corazon (Corsee) D. sold 2,000 shares of Common Stock in an open-market transaction at $25.05 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Ultragenyx Pharmaceutical Inc. director Sanders Corazon (Corsee) D. sold 2,000 shares of Common Stock in an open-market transaction at $25.05 per share. After this sale, the director directly holds 21,095 shares. The reported holdings include previously disclosed RSUs that will vest over time.
Insider Trade Summary
Net Seller: 2,000 shares
Net Sell
1 txn
Insider
Sanders Corazon (Corsee) D.
Role
Director
Sold
2,000 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,000 | $25.05 | $50K |
Holdings After Transaction:
Common Stock — 21,095 shares (Direct)
Footnotes (1)
- F1. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Key Figures
Shares sold: 2,000 shares
Sale price: $25.05 per share
Shares held after sale: 21,095 shares
+1 more
4 metrics
Shares sold
2,000 shares
Open-market sale of Common Stock
Sale price
$25.05 per share
Price for the 2,000 shares sold
Shares held after sale
21,095 shares
Direct ownership after transaction
Net shares sold
2,000 shares
Net-sell direction in this filing
Key Terms
open-market sale, Common Stock, RSUs, vesting conditions
4 terms
open-market sale financial
"executed an open-market sale of 2,000 shares of Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"sold 2,000 shares of Common Stock in an open-market transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
RSUs financial
"includes previously reported shares of common stock underlying RSUs granted"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
vesting conditions financial
"RSUs granted to the Reporting Person, which are subject to certain vesting conditions"
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ultragenyx (RARE) disclose for Sanders Corazon (Corsee) D.?
Ultragenyx reported that director Sanders Corazon (Corsee) D. executed an open-market sale of 2,000 shares of Common Stock. The transaction was recorded as a sale at a specified market price on the reported date.
Does the Ultragenyx (RARE) filing mention RSUs for the reporting person?
Yes. The filing notes that the reported holdings include shares underlying restricted stock units granted to the reporting person. These RSUs are subject to specific vesting conditions before they become fully owned shares of Common Stock.
Was the Ultragenyx (RARE) insider trade classified as an open-market sale?
Yes. The transaction is coded as an open-market sale of Common Stock. This indicates the shares were sold through regular trading channels, rather than through a private transaction or internal company program.
AI-generated analysis. How Rhea-AI works. Not financial advice.
